Tempest Therapeutics Inc — Cash Flow (NASDAQ:TPST) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -30.43 M-25.96 M-31.07 M-27.36 M-33.03 M-26.82 M -26.82 M Cash from investing activities -26 K-97 K-562 K-170 K-435 K0 0 Cash from financing activities 5.39 M59.06 M11.4 M35.6 M24.5 M4.26 M 4.26 M Free cash flow -30.46 M-26.09 M-31.63 M-27.53 M-33.46 M-26.82 M -26.82 M

News

New Strong Buy Stocks for April 10th

Tempest Therapeutics reports complete response in myeloma trial

Tempest Therapeutics stock surges after H.C. Wainwright upgrade

H.C. Wainwright upgrades Tempest Therapeutics stock rating to Buy with $11 target

Tempest Therapeutics receives Nasdaq notice for annual meeting compliance

Tempest Therapeutics closes $4.25 million registered direct offering

Tempest Therapeutics stock falls after $4.25 million direct offering

Tempest Therapeutics raises $4.25 million in registered direct offering

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs

Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results - Agios Pharmaceuticals (NASDAQ:AGIO), Carver Bancorp (NASDAQ:CARV)

Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast - Freight Technologies (NASDAQ:FRGT), Carver Bancorp (NASDAQ:CARV)